Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 420

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Clinical Features Predicting Mortality Risk in Patients With Viral Pneumonia: The MuLBSTA Score

Open access
Guo, Lingxi, Wei, Dong, Zhang, Xinxin, Wu, Yurong, Li, Qingyun, Zhou, Min, Qu, Jieming·2019·Frontiers in Microbiology

Abstract

Objective The aim of this study was to further clarify clinical characteristics and predict mortality risk among patients with viral pneumonia. Methods A total of 528 patients with viral pneumonia at RuiJin hospital in Shanghai from May 2015 to May 2019 were recruited. Multiplex real-time RT-PCR was used to detect respiratory viruses. Demographic information, comorbidities, routine laboratory examinations, immunological indexes, etiological detections, radiological images and treatment were collected on admission. Results 76 (14.4%) patients died within 90 days in hospital. A predictive MuLBSTA score was calculated on the basis of a multivariate logistic regression model in order to predict mortality with a weighted score that included multilobular infiltrates (OR=5.20, 95%CI 1.41-12.52, p=0.010; 5 points), lymphocyte≤0.8*109/L (OR=4.53, 95%CI 2.55-8.05, p<0.001; 4 points), bacterial coinfection (OR=3.71, 95%CI 2.11-6.51, p<0.001; 4 points), acute-smoker (OR=3.19, 95% CI 1.34-6.26, p=0.001; 3 points), quit-smoker (OR=2.18, 95% CI 0.99-4.82, p=0.054; 2 points), hypertension (OR=2.39, 95% CI 1.55-4.26, p=0.003; 2 points) and age≥60 years (OR=2.14, 95% CI 1.04-4.39, p=0.038; 2 points). 12 points was used as a cut-off value for mortality risk stratification. This model showed sensitivity of 0.776, specificity of 0.778 and a better predictive ability than CURB-65 (AUROC = 0.773 vs 0.717, p<0.001). Conclusions Here, we designed an easy-to-use clinically predictive tool for assessing 90-day mortality risk of viral pneumonia. It can accurately stratify hospitalized patients with viral pneumonia into relevant risk categories and could provide guidance to make further clinical decisions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fmicb.2019.02752

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 5

  1. Charles, 2009, Rocket science and the Infectious Diseases Society of America/American Thoracic Society (IDSA/ATS) guidelines for severe community-acquired pneumonia., Clin. Infect. Dis., 48, 10.1086/599227 · doi:10.1086/599227
  2. Chemaly, 2012, The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation., Blood, 119, 2738, 10.1182/blood-2011-08-371112 · doi:10.1182/blood-2011-08-371112
  3. Elizaga, 2001, Parainfluenza virus 3 infection after stem cell transplant: relevance to outcome of rapid diagnosis and ribavirin treatment., Clin. Infect. Dis., 32, 413, 10.1086/318498 · doi:10.1086/318498
  4. Lee, 2017, Comparison of Efficacy of Intravenous Peramivir and Oral Oseltamivir for the Treatment of Influenza: Systematic Review and Meta-Analysis., Yonsei Med. J., 58, 778, 10.3349/ymj.2017.58.4.778 · doi:10.3349/ymj.2017.58.4.778
  5. Uranga, 2018, Predicting 1-year mortality after hospitalization for community-acquired pneumonia., PloS One, 13, 10.1371/journal.pone.0192750 · doi:10.1371/journal.pone.0192750

Cited by

See all 420

Metadata

Authors
Guo, L., Wei, D., Zhang, X., Wu, Y., Li, Q., Zhou, M., & Qu, J.
Venue
Frontiers in Microbiology
Published
2019-12-03
Volume
10
Pages
2752-2752
ISSN
1664-302X (ISSN-L)
OpenAlex
W2991899552
Cited by
420
References
27
FWCI
57.13
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.